BROOMFIELD, Colo.--(BUSINESS WIRE)--Corgenix Medical Corporation (OTC BB: CONX), a worldwide developer and marketer of diagnostic test kits, reported sales of $2,011,996 for the third fiscal quarter ended March 31, 2007, compared with $1,634,446 for the quarter ended March 31, 2006, an increase of 23.1%. For the nine months ended March 31, 2007, Corgenix reported sales of $5,390,919, compared with $4,850,282 for the nine-month period the year prior. Increases in revenues for the quarter were primarily attributable to substantial growth in both the Company’s international business, across most product lines, and domestically in Corgenix’s contract manufacturing and OEM business.